Drug
Volitinib
Volitinib: highest development phase Phase 1, developed by United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Volitinib NCT01773018 | Phase 1 | Tumor |
| Volitinib(HMPL-504) NCT01985555 | Phase 1 | Tumors |
Latest
No recent events.
Follow Volitinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.